Literature DB >> 8105697

Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells.

J M Abbinante-Nissen1, L G Simpson, G D Leikauf.   

Abstract

Airway inflammation is often associated with the infiltration of activated neutrophils and subsequent protease release. Although aiding in the digestion and phagocytosis of foreign proteins and microorganisms, neutrophil proteases can indiscriminately damage healthy lung tissue. In the conducting airway, proteases, particularly neutrophil elastase, are counter-balanced by several antiproteases, including secretory leukocyte protease inhibitor (SLPI). SLPI can be produced locally by a number of cells including the airway epithelial cell. To examine the effects of neutrophil granule components on SLPI transcript levels, airway epithelial cells were treated (up to 96 h) with elastase, other proteases, or enzymes isolated from human sputum. We found that neutrophil elastase increased SLPI transcript levels in primary and transformed human airway epithelial cells in a time- and dose-dependent manner. Other neutrophil products, such as cathepsin G, myeloperoxidase, and lysozyme, had little or no effect on SLPI transcript levels. However, two nonneutrophil proteases, trypsin and pancreatic elastase, also increased SLPI transcript levels at higher doses than that required of neutrophil elastase. Two inflammatory cytokines, tumor necrosis factor-alpha and interleukin-8, produced little or no effect on SLPI transcript levels. This study demonstrates one way in which SLPI is regulated, via a protease that it inhibits, neutrophil elastase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105697     DOI: 10.1152/ajplung.1993.265.3.L286

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.

Authors:  F Jin; C F Nathan; D Radzioch; A Ding
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.

Authors:  Ganapathi Iyer Parameswaran; Sanjay Sethi; Timothy F Murphy
Journal:  Chest       Date:  2011-02-24       Impact factor: 9.410

Review 3.  Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.

Authors:  L Bingle; T D Tetley
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

4.  Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.

Authors:  N K Jana; L R Gray; D C Shugars
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Differences in distribution and synthesis of the functional opponents alpha 1-proteinase inhibitor and neutrophil elastase in eukaryotic cells.

Authors:  E Davids; A Ogilvie
Journal:  Histochem Cell Biol       Date:  1995-09       Impact factor: 4.304

6.  Role of salivary leukocyte protease inhibitor in periodontal disease progression.

Authors:  Deepak Pateel; H Seema; Akla Kale
Journal:  J Indian Soc Periodontol       Date:  2010-04

7.  Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.

Authors:  Camilla Hollander; Ulla Westin; Anders Wallmark; Eeva Piitulainen; Tomas Sveger; Sabina M Janciauskiene
Journal:  BMC Pulm Med       Date:  2007-01-29       Impact factor: 3.317

8.  Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.

Authors:  Anita L Sullivan; Timothy Dafforn; Pieter S Hiemstra; Robert A Stockley
Journal:  Respir Res       Date:  2008-08-12

Review 9.  Airway epithelial cell responses to ozone injury.

Authors:  G D Leikauf; L G Simpson; J Santrock; Q Zhao; J Abbinante-Nissen; S Zhou; K E Driscoll
Journal:  Environ Health Perspect       Date:  1995-03       Impact factor: 9.031

10.  Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.

Authors:  Camilla Hollander; Max Nyström; Sabina Janciauskiene; Ulla Westin
Journal:  Cancer Cell Int       Date:  2003-08-20       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.